Thomas E. Starzl
American physician (1926-2017)
A decade followup in early cases of renal homotransplantation.A review of adult and pediatric post-transplant liver pathology.A transplanter's credo.Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatmentAnimal research in liver transplantation with special reference to the dog.Antigen localization and migration in immunity and toleranceAspergillosis of the CNS in a pediatric liver transplant recipient: case report and reviewAugmenter of liver regeneration: its place in the universe of hepatic growth factorsBetween Scylla and Charybdis.Bone marrow augmentation in renal transplant recipients.Cell migration and chimerism--a unifying concept in transplantation--with particular reference to HLA matching and tolerance induction.Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptanceCell migration, chimerism, and graft acceptanceCellular transplantation and gene therapyCellular transplants.Changing concepts: liver replacement for hereditary tyrosinemia and hepatomaChanging perspectives on liver transplantation in 1988.Chimerism after organ transplantationChimerism after whole organ transplantation: its relationship to graft rejection and tolerance induction.Chimerism and tolerance in transplantationChimerism and xenotransplantation. New conceptsChronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allograftsClinical considerations in orthotopic liver transplantationClinical pharmacokinetics of tacrolimus.Clinical trials and projected future of liver xenotransplantation.Current perspectives of transplantation immunology via the intestine.Current status of intestinal transplantation.Current status of liver transplantationDonor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantationDonor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantationDrug development and testing in relation to cell migration and chimerism.Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disordersEvolution of liver transplantationExplanation for loss of the HLA matching effectFK506 in solid organ transplantation.FK 506 and autoimmune disease: perspective and prospectsFK 506 in solid organ transplantation.FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of PittsburghFK 506 versus cyclosporine.Hepatic regeneration and growth factors.
author
children
Thomas E. Starzl
American physician (1926-2017)
alternateName
Starzl T
@en
Starzl T. E.
@en
Starzl T.
@en
Starzl TE
@en
Starzl
@en
T E Starzl
@en
T Starzl
@en
T. E. Starzl
@en
T. Starzl
@en
Thomas E Starzl
@en
alumniOf
award
birthDate
1926-03-11T00:00:00Z
birthPlace
deathDate
2017-03-04T00:00:00Z
deathPlace
gender
homeLocation
knowsLanguage
mainEntityOfPage
memberOf
nationality
sameAs
comment
Ameerika Ühendriikide arst
@et
American physician (1926-2017)
@en
Amerikaans arts
@nl
US-amerikanischer Chirurg und ein Pionier der Transplantationsmedizin
@de
amerikai orvos
@hu
chirurgie américain
@fr
dochtúir Meiriceánach
@ga
dokter asal Amerika Serikat
@id
medic american
@ro
mediciste american
@lfn
label
Thomas E. Starzl
@cy
Thomas E. Starzl
@de
Thomas E. Starzl
@en
Thomas E. Starzl
@ga
Thomas E. Starzl
@pap
Thomas E. Starzl
@sq
Thomas Starzl
@ast
Thomas Starzl
@ca
Thomas Starzl
@cs
Thomas Starzl
@da